ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
2026 ARDC Annual Survey is now open!

The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your interaction with the ARDC and use of our national research infrastructure and services. The survey will take approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure services including Reasearch Link Australia.

We will use the information you provide to improve the national research infrastructure and services we deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program.

Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.

Complete the 5 min survey now by clicking on the link below.

Take Survey Now

Thank you.

  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : Project Grants
Research Topic : Bacterial virulence mechanisms
Clear All
Filter by Field of Research
Medical Bacteriology (73)
Medical Microbiology not elsewhere classified (12)
Basic Pharmacology (9)
Biochemistry and Cell Biology not elsewhere classified (8)
Central Nervous System (8)
Innate Immunity (6)
Sensory Systems (6)
Structural Biology (incl. Macromolecular Modelling) (6)
Medical Virology (5)
Gastroenterology and Hepatology (4)
Neurogenetics (4)
Neurology and Neuromuscular Diseases (4)
Respiratory Diseases (4)
Biologically Active Molecules (3)
Cancer Cell Biology (3)
Developmental Genetics (incl. Sex Determination) (3)
Genomics (3)
Peripheral Nervous System (3)
Signal Transduction (3)
Biomolecular Modelling and Design (2)
Cell Development, Proliferation and Death (2)
Cellular Immunology (2)
Cellular Nervous System (2)
Dentistry not elsewhere classified (2)
Enzymes (2)
Infectious Diseases (2)
Intensive Care (2)
Medical Parasitology (2)
Medical and Health Sciences not elsewhere classified (2)
Molecular Targets (2)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (226)
Filter by Status
Closed (226)
Filter by Scheme
Project Grants (226)
Filter by Country
Australia (28)
Filter by Australian State/Territory
VIC (15)
NSW (8)
QLD (6)
SA (2)
WA (2)
ACT (1)
  • Researchers (0)
  • Funded Activities (226)
  • Organisations (33)
  • Funded Activity

    Systems-level Characterisation And Therapeutic Targeting Of Small RNAs In Acinetobacter Baumannii Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $581,990.00
    Summary
    This proposal aims to understand how a superbug that causes severe infections in hospitalised patients worldwide and is known to be resistant to almost all available antibiotics, causes disease. We then plan on using this information to guide the development of a new type of therapy to treat this severe infection.
    More information
    Funded Activity

    Manipulation Of Clathrin-mediated Trafficking By Coxiella

    Funder
    National Health and Medical Research Council
    Funding Amount
    $667,857.00
    Summary
    This research will uncover how Coxiella causes the serious infectious disease Q fever by commandeering human cells and replicating to high numbers within a specialised vacuole. We will investigate virulence factors of Coxiella, learning how and why they target an essential human vesicular trafficking process. Our innovative approach and unique expertise will elucidate interaction between this pathogen and the human cell, providing fundamental knowledge towards public health outcomes.
    More information
    Funded Activity

    Role Of Autotransporter Proteins In Uropathogenic E. Coli Infections

    Funder
    National Health and Medical Research Council
    Funding Amount
    $611,149.00
    Summary
    Urinary tract infections (UTI) are among the most common infectious diseases of humans. Uropathogenic E. coli (UPEC), the primary cause of UTI, utilize a range of adherence mechanisms to colonize the urinary tract. In this project we will characterise the function and mode of secretion for one important class of UPEC adherence factors – autotransporter proteins. This work may inform new approaches to prevent UTI, an urgent need given the rapid increase in resistance to antibiotics among UPEC.
    More information
    Funded Activity

    The Impact Of Clostridium Difficile Infection And The Host Immune Response On Colonic Homeostasis And Regeneration.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $932,212.00
    Summary
    Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with highly virulent isolates emerging overseas in 2002 and in Australia in 2010. These have spread through our hospitals and are also found in the community. This project will increase our understanding of how these strains cause severe gut disease, which is critical for the development of improved strategies for preventing and treating these infections and reducing antibiotic use.
    More information
    Funded Activity

    Expression And Secretion Of Large Clostridial Toxins From The Pathogenic Clostridia.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $332,258.00
    Summary
    The large clostridial toxins are an important family of bacterial virulence factors that includes toxins from many disease-causing clostridial species. Despite their impact on public health, pathogenesis of disease caused by these bacteria is poorly understood. We will analyse how these bacteria regulate the production and secretion of the large toxins, which will give us a better understanding of the mechanisms of disease causation as well as identifying novel common therapeutic targets.
    More information
    Funded Activity

    The Role Of Clostridium Difficile Spore Surface Structures In Initiating Gastrointestinal Infection And Disease.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $467,556.00
    Summary
    Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with more virulent isolates emerging overseas since 2000. These strains were detected in Australia in 2010 and are now spreading throughout our hospitals. This project will increase our understanding of how these strains are transmitted to susceptible hosts and why they are so harmful, which is critical for the development of better strategies for preventing and treating these infection .... Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with more virulent isolates emerging overseas since 2000. These strains were detected in Australia in 2010 and are now spreading throughout our hospitals. This project will increase our understanding of how these strains are transmitted to susceptible hosts and why they are so harmful, which is critical for the development of better strategies for preventing and treating these infections.
    Read more Read less
    More information
    Funded Activity

    Evolution And Pathogenicity Of NDM-1 Positive Escherichia Coli

    Funder
    National Health and Medical Research Council
    Funding Amount
    $643,275.00
    Summary
    Antibiotic resistance (AR), as highlighted by the WHO, is the most pressing medical need of the 21C – some infections are now untreatable. Our research will focus on the new "superbug" NDM-1 positive E. coli. We will correlate AR and pathogenicity and explore the evolution of these "superbugs" using state-of-the-art sequencing. This research will benefit Australian medicine by predicting timelines of AR epidemics and by conducting the first analyses on the virulence potential of these strains.
    More information
    Funded Activity

    Integrated Bacterial Genomics And Virulence Analysis Of Uropathogenic Streptococcus Agalactiae

    Funder
    National Health and Medical Research Council
    Funding Amount
    $747,457.00
    Summary
    Urinary tract infections (UTI), which start as a bladder infection and often evolve to encompass the kidneys, are among the most common infectious diseases in humans. Streptococcus agalactiae is an important cause of gram-positive bacterial UTI. We will study the genomes and functions of specific genes in reference strains of this bacterium isolated from patients with different forms of infection to elucidate how bacterial genes and virulence factors contribute to these types of infections.
    More information
    Funded Activity

    The Role Of Clostridium Difficile Virulence Factors In Mediating The Host-pathogen Interactions That Lead To Gastrointestinal Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $444,351.00
    Summary
    Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with more virulent isolates emerging overseas since 2000. These strains were detected in Australia in 2010 and are now spreading throughout our hospitals. This project will increase our understanding of how these strains cause disease and why they are more harmful, which is critical for the development of improved strategies for preventing and treating these infections.
    More information
    Funded Activity

    ROLE OF RIP KINASES & IAPs IN MUCOSAL IMMUNE DEFENCE

    Funder
    National Health and Medical Research Council
    Funding Amount
    $631,168.00
    Summary
    Pathogenic bacteria are master manipulators of the inflammatory signalling pathways designed to thwart them. Understanding how they do this will allow us to develop drugs that limit their ability to infect. We have shown that pathogenic bacteria inject a protein called EspL into human cells to promote the destruction of a family of human proteins, called RIP Kinases (RIPK), that co-ordinate the inflammatory response and aim now to discover how EspL causes RIPK degradation and thereby promotes in .... Pathogenic bacteria are master manipulators of the inflammatory signalling pathways designed to thwart them. Understanding how they do this will allow us to develop drugs that limit their ability to infect. We have shown that pathogenic bacteria inject a protein called EspL into human cells to promote the destruction of a family of human proteins, called RIP Kinases (RIPK), that co-ordinate the inflammatory response and aim now to discover how EspL causes RIPK degradation and thereby promotes infection.
    Read more Read less
    More information

    Showing 1-10 of 226 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback